IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1

CUSIP: 46333XAD0

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Debt / DBCV 2.250% 6/1
Market price (% of par)
106.95%
Total 13F principal
$264,710,153
Principal change
-$27,609,047
Total reported market value
$286,598,293
Number of holders
32
Value change
-$31,001,949
Number of buys
16
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 46333XAD0?
CUSIP 46333XAD0 identifies 46333XAD0 - IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 as of Q2 2019

As of 30 Jun 2019, IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 was held by 32 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $264,710,153 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, DeepCurrents Investment Group LLC, HBK INVESTMENTS L P, UBS ASSET MANAGEMENT AMERICAS INC, Verition Fund Management LLC, H2O AM LLP, CAPSTONE INVESTMENT ADVISORS, LLC, CSS LLC/IL, and CALAMOS ADVISORS LLC. This page lists 32 institutional bondholders reporting positions for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.